UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

PLoS pathogens, 2015-09, Vol.11 (9), p.e1005142-e1005142

2015

Link zum Volltext

Verfügbarkeit prüfen

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

PloS one, 2019-01, Vol.14 (1), p.e0210965-e0210965

2019

Link zum Volltext

Verfügbarkeit prüfen

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials

BMJ (Online), 2001-11, Vol.323 (7322), p.1151

International edition, 2001

Link zum Volltext

Verfügbarkeit prüfen

Glucocorticosteroids for viral hepatitis B

Cochrane database of systematic reviews, 2018-09, Vol.2018 (9)

2018

Link zum Volltext

Verfügbarkeit prüfen

Incidence and clinical presentation of groin injuries in sub-elite male soccer

British journal of sports medicine, 2014-08, Vol.48 (16), p.1245-1250

2014

Link zum Volltext

Verfügbarkeit prüfen

Genotype Mixtures of Hepatitis B Virus in Patients Treated with Interferon

The Journal of infectious diseases, 2002-09, Vol.186 (6), p.752-759

2002

Link zum Volltext

Verfügbarkeit prüfen

Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity

European journal of endocrinology, 2022-06, Vol.186 (6), p.687

2022

Link zum Volltext

Verfügbarkeit prüfen

Mapping international impact of Danish neuroscience from 2004 to 2015 using tailored scientometric methodology

The European journal of neuroscience, 2018-02, Vol.47 (3), p.193-200

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting

Journal of cardiothoracic and vascular anesthesia, 2004-12, Vol.18 (6), p.709-714

2004

Link zum Volltext

Verfügbarkeit prüfen

The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects

Cytokine (Philadelphia, Pa.), 2015-04, Vol.72 (2), p.197-203

2015

Link zum Volltext

Verfügbarkeit prüfen

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study

Journal of rheumatology, 2004-04, Vol.31 (4), p.783

2004

Link zum Volltext

Verfügbarkeit prüfen

ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hypothalamic Obesity

Journal of the Endocrine Society, 2022-11, Vol.6 (Supplement_1), p.A509-A509

2022

Link zum Volltext

Verfügbarkeit prüfen

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity

Journal of the Endocrine Society, 2021-05, Vol.5 (Supplement_1), p.A64-A65

2021

Link zum Volltext

Verfügbarkeit prüfen

Would you trust a surrogate respondent?

The Lancet (British edition), 1997-03, Vol.349 (9053), p.665-666

1997

Link zum Volltext

Verfügbarkeit prüfen

Chlamydia pneumoniae antibodies and endothelial function as assessed by flow-mediated dilation in patients with chest pain with and without ischemic heart disease

The American journal of cardiology, 2003-04, Vol.91 (8), p.982-985

2003

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of active physical training as treatment for long-standing adductor-related groin pain in athletes: randomised trial

The Lancet (British edition), 1999-02, Vol.353 (9151), p.439-443

1999

Link zum Volltext

Verfügbarkeit prüfen

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials

Journal of hepatology, 1994, Vol.21 (4), p.646-655

1994

Link zum Volltext

Verfügbarkeit prüfen

Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study

Journal of viral hepatitis, 2009-09, Vol.16 (9), p.659-665

2009

Link zum Volltext

Verfügbarkeit prüfen

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo: e1005142

PLoS pathogens, 2015-09, Vol.11 (9)

2015

Link zum Volltext

Verfügbarkeit prüfen

The depsipeptide romidepsin reverses HIV-1 latency in vivo

PLoS pathogens, 2015-09, Vol.11 (9)

2015

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study

BMC infectious diseases, 2011-06, Vol.11 (1), p.177-177, Article 177

2011

Link zum Volltext

Verfügbarkeit prüfen

Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection

International journal of molecular sciences, 2015-02, Vol.16 (2), p.3213-3225

2015

Link zum Volltext

Verfügbarkeit prüfen

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C

Scandinavian journal of gastroenterology, 2012-09, Vol.47 (8-9), p.1115-1119

2012

Link zum Volltext

Verfügbarkeit prüfen

HBeAg and not genotypes predicts viral load in patients with hepatitis B in Denmark: A nationwide cohort study

Scandinavian journal of gastroenterology, 2011-12, Vol.46 (12), p.1484-1491

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(109)
Buchkapitel
(1)

Sprache

Englisch
(99)
Dänisch
(11)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials

Glucocorticosteroids for viral hepatitis B

Incidence and clinical presentation of groin injuries in sub-elite male soccer

Genotype Mixtures of Hepatitis B Virus in Patients Treated with Interferon

Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity

Mapping international impact of Danish neuroscience from 2004 to 2015 using tailored scientometric methodology

Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting

The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study

ODP350 Safety and Efficacy of Tesomet over 48 Weeks of Treatment: Results From a 24-Week Phase 2, Randomized, Double-Blind Study With 24 Week Open-Label Extension in Adults With Hypothalamic Obesity

Weight Loss, Improved Body Composition and Fat Distribution by Tesomet in Acquired Hypothalamic Obesity

Would you trust a surrogate respondent?

Chlamydia pneumoniae antibodies and endothelial function as assessed by flow-mediated dilation in patients with chest pain with and without ischemic heart disease

Effectiveness of active physical training as treatment for long-standing adductor-related groin pain in athletes: randomised trial

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials

Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo: e1005142

The depsipeptide romidepsin reverses HIV-1 latency in vivo

Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: a Danish nationwide cohort study

Genetic variants in the apoptosis gene BCL2L1 improve response to interferon-based treatment of hepatitis C virus genotype 3 infection

Negative HCV-RNA 2 weeks after initiation of treatment predicts sustained virological response to pegylated interferon alfa-2a and ribavirin in patients with chronic hepatitis C

HBeAg and not genotypes predicts viral load in patients with hepatitis B in Denmark: A nationwide cohort study

Suchergebnisse filtern